Lupus

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Choon Lee Wang,
Right arrow Articles by Bosco, J. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Choon Lee Wang,
Right arrow Articles by Bosco, J. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Lupus, Vol. 4, No. 1, 11-14 (1995)
DOI: 10.1177/096120339500400103

Ovarian failure in oral cyclophosphamide treatment for systemic lupus erythematosus

Choon Lee Wang

Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

Florence Wang

Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

John Joseph Bosco

Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia

Ninety-two women with systemic lupus erythematosus treated with oral cyclophosphamide were studied to ascertain the prevalence and the factors associated with ovarian dysfunction. Menstrual disturbance during treatment occurred in 55% of patients: 36% had amenorrhoea and 19% had oligomenorrhoea. Sustained oligomenorrhoea occurred in 12% patients. Permanent amenorrhoea (> 12 months) after cessation of oral cyclophosphamide occurred in 27% of patients. Hormonal studies in these patients were consistent with ovarian failure. Older age at initiation of treatment and high cumulative dose of cyclophosphamide were found to be associated with this outcome. There was a trend towards linear relationship between the age of initiation of cyclophosphamide therapy and frequency of amenorrhoea. A statistically significant association between amenorrhoea and cumulative dose of cyclophosphamide after adjustment for age was found whereas no such association was linked to the duration of treatment. Fourteen of the 23 women who wished to become pregnant after cessation of treatment conceived resulting in 20 live births and two abortions.

Key Words: Systemic lupus erythematosus • Cyclophosphamide • Amenorrhoea


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
LupusHome page
M Lidar, G Zandman-Goddard, Y Shinar, N Zaks, A Livneh, and P Langevitz
Systemic lupus erythematosus and familial Mediterranean fever: a possible negative association between the two disease entities - report of four cases and review of the literature
Lupus, July 1, 2008; 17(7): 663 - 669.
[Abstract] [PDF]